Long-term safety of common ADHD medication for children and adolescents, global team finds. Long-term use of methylphenidate, the most commonly prescribed medication for treating ADHD, does not increase the risk of adverse developmental and psychiatric outcomes in children and adolescents, an international research team has found. The findings have led experts to argue for the […]
Read More… from Long-term safety confirmed for common ADHD medication
ADHD at university: Why diagnosis, treatment and greater inclusivity is so important, says Priory expert. ADHD Awareness Month occurs annually throughout October and is dedicated to raising awareness of and educating the public about Attention Deficit Hyperactivity Disorder. An estimated 2.6million people in the UK are living with ADHD, with official figures giving a childhood […]
Read More… from ADHD at University – diagnosis is the key to success
New research provides reassurance that the most common ADHD drug is not linked to psychotic symptoms The most commonly prescribed ADHD drug methylphenidate does not increase the risk of psychotic episodes in patients, according to experts from the University of Nottingham. In the new study, published in The Lancet Psychiatry, experts found no evidence that […]